SILENT MYOCARDIAL ISCHEMIA AND CARDIAC RHYTHM DISTURBANCES IN WOMEN WITH RHEUMATOID ARTHRITIS

Objective: to assess the rate of silent myocardial ischemia (SMI) and the pattern of cardiac rhythm disturbances in women with rheumatoid
arthritis (RA), their association with traditional risk factors (TRF) for cardiovascular diseases (CVD), with subclinical structural and functional
changes in the heart and vessels, with the activity and severity of rheumatoid inflammation.

Subjects and methods. Two hundred and ninety-one female patients aged less than 60 years with a valid diagnosis of RA and no clinical
signs were examined. A control group consisted of 125 women without rheumatic diseases. In addition to the clinical manifestations, activity,
and severity of RA, the authors assessed major TRFs for CVD, performed Holter ECG monitoring, common carotid artery duplex scanning, transthoracic echocardiographic study, and determined the levels of serum inflammatory markers.

Results. The women with RA differ from the control group in the higher incidence of SMI, supraventricular arrhythmias (SVA) and highgrade
premature ventricular contractions (PVC). The patients with RA and SMI are characterized in terms of age-adjustment by higher disease activity (DAS28), systemic manifestations), cumulative larger-dose glucocorticoids (GC) and a higher percentage of patients receiving disease-modifying anti-rheumatic drugs as compared with those with RA and no SMI with adjustment for age. High disease activity
(DAS28, level of inflammatory markers), IgM rheumatoid arthritis seropositivity, and GC therapy are SVA-associated factors in women with RA; larger left ventricular end-diastolic dimension and serositis are factors associated with high-grade PVC.

Conclusion. The RA women without clinical manifestations of CVD are recorded to have high rates of SMI, SVA, and high-grade PVC, which is primarily due to the activity and severity of rheumatoid inflammation.

1. Ревматология. Клинические рекомендации. Под ред. акад. РАМН Е. Л. Насонова. М.: ГЭОТАР-Медиа, 2010.

2. Попкова Т. В., Новикова Д. С., Насонов Е. Л. Атеросклероз при ревматических заболеваниях. В кн.: Ревматология. Клинические рекомендации. M.: ГЭОТАР-Медиа, 2010. С. 678–702.

3. Peters M. J., Symmons D. P., McCarey D. et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other types of inflammatory arthritis. Ann Rheum Dis 2010;69(2):325–31.

4. Meune C., Touze E., Trinqurte L., Allanore Y. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 2009;48(10):1309–13.

5. Warrington K. J., Kent P. D., Frye R. L. et al. Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther 2005;7(5):R984–91.

6. Douglas K. M., Pace A. V., Treharne G. J. et al. Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann Rheum Dis 2006;65(3):348–53.

7. Södergren A., Stegmayr B., Lundberg V. et al. Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis. Ann Rheum Dis 2007;66(2):263–6.

8. Maradit-Kremers H., Crowson C. S., Nicola P. J. et al. Increased unrecognized coronary heart disease and sudden deaths rheumatoid arthritis. A population-based controlled study. Arthritis Rheum 2005;52(2):402–41.

9. Maradit-Kremers H., Nicola P. J., Crowson C. S. et al. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005;52(3):722–32.

10. Верткин A. Л., Мартынов И. В., Гасилин B. C. и др. Безболевая ишемия миокарда. М.: Тетрафарм, 1995.

11. Кондратьев В. В., Бочкарева Е. В., Кокурина Е. В. Безболевая ишемия миокарда. Современное состояние проблемы и клинически значимые аспекты ее развития. Кардиология 1997;(2):90–7.

12. Дабровски А., Дабровски Б., Пиотрович Р. Суточное мониторирование ЭКГ. Перевод: Корнеев Н. В., Грабко Н. Н., Банникова С. Д. М.: Медпрактика, 2000.

13. Стрюк Р. И., Леонова Е. А., Гостева О. В., Тедикова Н. С. Безболевая ишемия миокарда у больных ревматоидным артритом. Тер архив 2008;80(5):16–20.

14. Galiutina O., Bychak O. V. Relationship of silent myocardial ischiemia with the course of rheumatoid arthritis and hyperhomocysteinemia. [Article in Ukrainian]. Lik Sprava 2011;(1–2):48–52.

15. Леонова Е. А., Стрюк Р. И. Оценка суточного мониторирования ЭКГ у больных ревматоидным артритом. Науч-практ ревматол 2006;(2):94.

16. Wisłowska M., Sypuła S., Kowalik I. Echocardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis. Rheumatol Int 1999;18(5–6):163–9.

17. Махнырь Е. Ф., Голоухова Л. М., Головко Е. В. Нарушения ритма сердца у больных ревматоидным артритом как проявление ревматоидной болезни сердца. Вестн РГМУ 2009;(7):45–8.

18. Колотова Г. Б., Гришина И. Ф. Нарушения ритма и проводимости сердца у пациентов с серопозитивным и серонегативным ревматоидным артритом. Ультразвук и функцион диагност 2008;(2):64–9.

19. Tłustochowicz W., Piotrowicz R., Cwetsch A. et al. 24-h ECG monitoring in patients with rheumatoid arthritis. Eur Heart J 1995;16(6):848–51.

20. Arnett F. C., Edworthy S. M., Bloch D. A. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31(3):315–24.

21. De Backer G., Ambrosioni E., Borch-Johnsen K. et al. European guidelines on cardiovascular disease and prevention in clinical practice. Atherosclerosis 2003;171(1):145–55.

22. Howard G., Sharrett A. R., Heiss G. et al. Carotid artery intima-media thickness distribution in general populations as evaluated by B-mode ultrasound. Stroke 1993;24(9):1297–304.

23. Диагностика и лечение артериальной гипертензии. Национальные клинические рекомендации. Сборник. Под ред. Р. Г. Оганова. 2-е изд. М.: Силицея-Полиграф, 2009. С. 292–332.

24. Национальные рекомендации ВНОК и ОССН по диагностике и лечению хронической сердечной недостаточности (третий пересмотр). Сердечн недостат 2010;11(1):3–62.

25. Герасимов А. Н. Медицинская статистика: учебное пособие. М.: ООО «Медицинское информационное агентство», 2007.

26. Крамeр Г. Математические методы статистики. 2-е изд. Пер. с англ. М.: Мир, 1975.

27. Gabriel S. E. Why do people with rheumatoid arthritis still die prematurely? Ann Rheum Dis 2008;67(Suppl 3):iii30–4.

28. Khovidhunkit W., Kim M. S., Memon R. A. et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 2004;45(7):1169–96.

29. Escalante A., Haas R. W., del Rincon I. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role for comorbidity and systemic inflammation. Arch Intern Med 2005;167(14):1624–29.

30. Giles J. T., Fernandes V., Lima A. C., Bathon J. M. Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Artritis Res Ther 2005;7(5):195–207.

31. Aubry M. C., Maradit-Kremers H., Reinalda M. S. et al. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol 2007;34(5):937–42.

32. Seforovic P. M., Ristic A. D., Maksimovic R. et al. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic disease. Rheumatology (Oxford) 2006;45(Suppl 4):iv39–42.

33. Kumari R., Uppal S. S. First report of supraventricular tachycardia after intravenous pulse methylprednisolone therapy, with a brief review of the literature. Rheumatol Int 2005;26(1):70–3.

34. Athern M., Lever J. V., Cosh J. Complete heart block in rheumatoid arthritis. Ann Rheum Dis 1983;42(4):389–97.

35. Ozgül M., Hoşcan Y., Arslan C., Karabacak M. Complete atrioventricular block in a patient with rheumatoid arthritis [in Turkish]. Turk Kardiyol Dern Ars 2008;36(4):263–5.

36. Okada Y., Nakanishi I., Kajikawa K., Kawasaki S. An autopsy case of rheumatoid arthritis with an involvement of the cardiac conduction system. Jpn Circ J 1983;47(6):671–6.